Assaf Segal

Assaf Segal currently serves as the Chief Executive Officer and Chief Financial Officer at Clal Biotechnology Industries since July 2015. In addition, Assaf is a Managing Partner at Anatomy Medical Technologies and holds board member positions at several companies, including eXIthera Pharmaceuticals LLC, Elicio Therapeutics, MediWound Ltd., FDNA, Pi-Cardia, Biokine Therapeutics Ltd., and Colospan Ltd. Assaf's educational background includes an MBA in Finance and Information Systems and a B.A. in Economics and Statistics from The Hebrew University of Jerusalem, and participation in the Executive HealthTech Leadership Program at Harvard Business School.